MA29105B1 - Amplificateur de l'effet d'un adrenocorticoide, contenant de la gomme arabique - Google Patents

Amplificateur de l'effet d'un adrenocorticoide, contenant de la gomme arabique

Info

Publication number
MA29105B1
MA29105B1 MA30018A MA30018A MA29105B1 MA 29105 B1 MA29105 B1 MA 29105B1 MA 30018 A MA30018 A MA 30018A MA 30018 A MA30018 A MA 30018A MA 29105 B1 MA29105 B1 MA 29105B1
Authority
MA
Morocco
Prior art keywords
adrenocorticoid
amplifier
effect
arabic gum
containing arabic
Prior art date
Application number
MA30018A
Other languages
English (en)
Inventor
Michinori Kubo
Hideaki Matsuda
Original Assignee
Veritron Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Veritron Ltd filed Critical Veritron Ltd
Publication of MA29105B1 publication Critical patent/MA29105B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medical Informatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
MA30018A 2004-11-30 2007-06-18 Amplificateur de l'effet d'un adrenocorticoide, contenant de la gomme arabique MA29105B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004346673 2004-11-30

Publications (1)

Publication Number Publication Date
MA29105B1 true MA29105B1 (fr) 2007-12-03

Family

ID=36250826

Family Applications (1)

Application Number Title Priority Date Filing Date
MA30018A MA29105B1 (fr) 2004-11-30 2007-06-18 Amplificateur de l'effet d'un adrenocorticoide, contenant de la gomme arabique

Country Status (17)

Country Link
US (1) US20090060944A1 (fr)
EP (1) EP1817040A2 (fr)
JP (1) JP2008521791A (fr)
KR (1) KR20070084588A (fr)
CN (1) CN101232889A (fr)
AP (1) AP2007004022A0 (fr)
AU (1) AU2005310453A1 (fr)
BR (1) BRPI0518712A2 (fr)
CA (1) CA2584136A1 (fr)
IL (1) IL182951A0 (fr)
MA (1) MA29105B1 (fr)
MX (1) MX2007006365A (fr)
NO (1) NO20073379L (fr)
RU (1) RU2007124549A (fr)
TW (1) TW200631590A (fr)
WO (1) WO2006059764A2 (fr)
ZA (1) ZA200704404B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200803883A (en) * 2005-09-22 2008-01-16 Veritron Ltd Enhancer of cholinesterase activity
DE102006061517A1 (de) * 2006-12-18 2008-06-19 Eberhard-Karls-Universität Tübingen Universitätsklinikum Angioinhibin
DE102007039310A1 (de) * 2007-08-13 2009-02-19 Eberhard-Karls-Universität Tübingen Universitätsklinikum Zusammensetzung zur Prophylaxe und Behandlung von Osteoporose

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB841998A (en) * 1956-11-28 1960-07-20 Merck & Co Inc Steroid compounds
US5554386A (en) * 1986-07-03 1996-09-10 Advanced Magnetics, Inc. Delivery of therapeutic agents to receptors using polysaccharides

Also Published As

Publication number Publication date
JP2008521791A (ja) 2008-06-26
CN101232889A (zh) 2008-07-30
IL182951A0 (en) 2007-09-20
WO2006059764A2 (fr) 2006-06-08
KR20070084588A (ko) 2007-08-24
TW200631590A (en) 2006-09-16
CA2584136A1 (fr) 2006-06-08
MX2007006365A (es) 2007-06-20
NO20073379L (no) 2007-06-29
AU2005310453A1 (en) 2006-06-08
BRPI0518712A2 (pt) 2008-12-02
WO2006059764A3 (fr) 2007-04-19
RU2007124549A (ru) 2009-01-10
EP1817040A2 (fr) 2007-08-15
AP2007004022A0 (en) 2007-06-30
US20090060944A1 (en) 2009-03-05
ZA200704404B (en) 2008-08-27

Similar Documents

Publication Publication Date Title
EP1784175A4 (fr) Inhibiteurs de l'activite de akt
EP1827436A4 (fr) Inhibiteurs d'activite akt
EP1620095A4 (fr) Inhibiteurs de l'activite akt
EP1737861A4 (fr) Inhibiteurs de l'activite d'akt
EP1506786A4 (fr) Compositions medicinales contenant de la ghreline
EP1552814A4 (fr) Composition de fragrance
NO20040606L (no) Opphengskonstruksjon for rullestol.
EP1898903A4 (fr) Inhibiteurs de l'activite akt
BR0318134B1 (pt) "porta de enrolar"
IS7571A (is) Ný lífeðlisfræðilega virk efni
EP1930358A4 (fr) Composition de polyisocyanate et composition de revêtement la contenant
ITFI20030318A1 (it) Dispositivo e metodo per l'eliminazione di rifili da
ZA200500485B (en) Enzyme enhanced breath freshening film
MA29105B1 (fr) Amplificateur de l'effet d'un adrenocorticoide, contenant de la gomme arabique
EP1824849A4 (fr) Inhibiteurs de l'activite de akt
EP1599206A4 (fr) Modulateurs d'heterotricylicamide fusionne avec un aminocyclopentyl de l'activite des recepteurs de la chimiokine
MA28527B1 (fr) Formulations orales contenant licarbazepine
DE602004009733D1 (de) Dynamisches Ratenteilungsverfahren
DE60326900D1 (de) Duftstoff-Zusammensetzung
ITMI20030778A1 (it) Procedimento per la preparazione enzimatica dell'aroma di vaniglia.
EP1717244A4 (fr) Polypeptide inhibant specifiquement l'activite d'akt
IS7539A (is) Sjálfskammtað getnaðarvarnarídælingarefni úr olíukenndri lausn.
FR2859010B1 (fr) Amplificateur de la force de freinage
ITMI20031025A1 (it) Composizione d'inchiostro.
SE0300447L (sv) Boggibroms